Navigation Links
NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share
Date:7/10/2014

BEDFORD, Mass., June 30, 2014 /PRNewswire/ -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software and services, previously announced on June 26, 2014 that its Board of Directors had declared a special cash dividend of $1.75 per share, or approximately $40 million in total.  The Board established a record date of July 10, 2014 and a payment date of July 24, 2014.  The Company was subsequently notified by NASDAQ that it had set an ex-dividend date for this special cash dividend.  An ex-dividend date of July 25, 2014 has been established by NASDAQ.

We encourage shareholders to contact their brokers in order to understand the Nasdaq Rules and Regulations regarding the effect of selling shares of our common stock following the record date on their eligibility to receive the dividend.

About Aware
Aware is a leading provider of biometrics software products and development services to governments, system integrators, and solution providers globally. Our products include SDKs, software components, workstation applications, and a modular, centralized, service-oriented platform. They fulfill a broad range of functions critical to biometric authentication and search, including face, fingerprint, and iris autocapture, image quality assurance, data compliance, capture hardware peripheral abstraction, centralized data processing and workflow, subsystem connectivity, and biometric matching algorithms. The products are used to enable identity-centric security solutions with biometrics for applications including border management, credentialing and access control, intelligence and defense, and law enforcement. Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts.

We refer you to
'/>"/>

SOURCE Aware, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. NASDAQ Sets Ex-Dividend Date for Aware, Inc.s Special Cash Dividend of $1.80 Per Share
2. Dynasil Regains Compliance with NASDAQ Listing Requirements
3. Aware, Inc. Reports First Quarter 2012 Financial Results
4. Aware, Inc. Reports Second Quarter 2012 Financial Results
5. Aware, Inc. Reports Third Quarter 2012 Financial Results
6. Aware, Inc. Declares Special Cash Dividend of $1.80 Per Share, or Approximately $40 Million in Total
7. Aware, Inc. Reports First Quarter 2013 Financial Results
8. Aware, Inc. Reports Second Quarter 2013 Financial Results
9. Aware, Inc. Reports Third Quarter 2013 Financial Results
10. Patient in vegetative state not just aware, but paying attention
11. Dinosaur fossil: Even specialized predators didnt turn down free meals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... TORONTO , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the ... announced the launch of its new website design. ... in its infancy", says Peter O,Neill , founder and ... ever, the industry needs involvement from the key players on ...
(Date:1/22/2015)... DETROIT , Jan. 13, 2015 Technology Showcase, Hall ... iris-based identity authentication solutions, today announced it will showcase its ... and developed by the Department of Energy,s Oak Ridge ... International Auto Show . EyeLock,s iris identity authentication technology is ...
(Date:1/22/2015)... N.C. , Jan. 16, 2015  A man-made form ... memory and other mental capabilities in adults with mild ... pilot study led by researchers at Wake Forest Baptist ... adults diagnosed with amnesic mild cognitive impairment (MCI) or ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... has revealed that the extremely hot, dry and windy conditions ... ,horizontal convective rolls, -similar to streamers of wind flowing through ... study is the first of its kind to produce such ... provides insights for future fire management and warning systems. ...
... looking for information on the evolution and function ... Ravosa is your man. His integrative research ... the mammalian musculoskeletal system during development and across ... increasingly central role of the chewing complex in ...
... international research collaboration recently demonstrated progress in protecting cassava ... disease, in a confined field trial in Uganda using ... planted in November 2010 following approval by the National ... in November 2011 and results were published in the ...
Cached Biology News:Unusual weather events identified during the Black Saturday bushfires 2Notre Dame researcher is shedding light on how jaws evolve 2Researchers demonstrate control of devastating cassava virus in Africa 2
(Date:2/26/2015)... PHILADELPHIA , Feb. 26, 2015  Spark Therapeutics (NASDAQ: ... its management team will participate in the Cowen and ... at 9:40 a.m., Eastern, at the Boston Marriott Copley ... a Spark Therapeutics presentation from the Cowen conference, please ... Events" section of the Spark Therapeutics website at ...
(Date:2/26/2015)... 26, 2015 On Wednesday, February 25, ... a nationwide Clostridium difficile (C. diff) awareness movement, lauded ... study by the Centers for Disease Control & Prevention ... half a million infections among Americans in a single ... , The study also estimates that 29,000 patients ...
(Date:2/26/2015)... 26, 2015 Phosphate Therapeutics, ... the first pivotal trial of PT20 in subjects ... disease (DD-CKD), has completed as the pre-specified number ... invented by leading UK-based scientists from the Medical ... is a novel phosphate binder that is based ...
(Date:2/25/2015)... 25, 2015 truBrain , creator ... in this week,s Power Pitch segment of CNBC,s  ... the company,s traction and growth strategy, as well ... funding site CircleUp. The segment highlights ... validated by neurotechnology, while also discussing its decision ...
Breaking Biology Technology:Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 3Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 4Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3CNBC's Power Lunch Features Neurotechnology Start-up truBrain 2
... researchers have found that the body,s innate ability to ... more effective and less costly artificial respirators. The new ... or paralysis currently necessary for some patients on mechanical ... adapt to recurring stimuli, is the focus of work ...
... Rice University chemists have discovered a way to load ... gold spheres. The result is a tiny ball, many times ... drug. , Paclitaxel, which is sold under the brand name ... works. , "Paclitaxel is one of the most effective anti-cancer ...
... new approach to discover life on Mars were successfully ... low-Earth orbit experiment to assess their survivability in the ... The new approach is based on technology similar to ... are embodied in the Life Marker Chip (LMC) experiment, ...
Cached Biology Technology:MIT: Leveraging learning for artificial respiration 2Taxol bristle ball: a wrench in the works for cancer 2Life on Mars 'pregnancy test' successfully launched 2
...
...
... Mouse polyclonal antibody raised against ... Immunogen: K6HF ... a.a) partial recombinant protein with ... Accession Number: NM_004693 ...
... role in the regulation of signaling pathways ... variants have been reported that affect both ... pathways. With Apoptosis and Cell Death ... profiling and at the same time detect ...
Biology Products: